+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice

Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice

Infection and Immunity 73(2): 956-964

Maternal antibodies (MatAbs) may protect the offspring against infections but may also interfere with their immune responses to vaccination. We have previously shown that maternal immunization with pneumococcal polysaccharides (PPS) conjugated to tetanus protein (Pnc-TT) protected the offspring against infections caused by three important pediatric serotypes. To study the influence of MatAb on the immune response to Pnc-TT early in life, adult female mice were immunized twice with Pnc-TT of serotype 1 (Pnc1-TT), and their offspring received Pnc1-TT subcutaneously three times at 3-week intervals starting at 1 week (neonatal) or 3 weeks (infant) of age. High levels of PPS-1-specific MatAb (>3 log) in offspring of Pnc1-TT-immunized dams completely inhibited their anti-PPS-1 response elicited by Pnc1-TT. In contrast, low or moderate ( approximately 1 to 2 log) levels of MatAb did not interfere with and even enhanced the immune response of the offspring, and a booster response to a second Pnc1-TT dose was observed. Carrier-specific MatAbs had little effect on the response of offspring to the conjugate. All Pnc1-TT-immunized offspring were protected against pneumococcal bacteremia and had reduced lung infection. These results demonstrate that in the presence of MatAb, Pnc1-TT may elicit a protective PPS-1-specific antibody response and prime for PPS-1-specific memory in young offspring. Importantly, low or moderate levels of PPS-1-specific MatAb not only provided protection against pneumococcal infections but also enhanced the immune response elicited by Pnc1-TT in neonatal and infant mice. This murine model will be used to develop novel strategies combining maternal and neonatal immunization to protect against infections caused by encapsulated bacteria in early life.

(PDF emailed within 0-6 h: $19.90)

Accession: 013178416

Download citation: RISBibTeXText

PMID: 15664938

DOI: 10.1128/IAI.73.2.956-964.2005

Related references

Functional differences in IgG anti-polysaccharide antibodies elicited by immunization of mice with C3d versus ovalbumin conjugates of pneumococcal serotype 14 capsular polysaccharide. Vaccine 23(1): 21-28, 2004

Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacy. European Journal of Immunology 36(2): 287-295, 2005

Maternal immunity and antibody response of neonatal mice to pneumococcal type 19F polysaccharide. Journal of Clinical Microbiology 29(9): 1904-1909, 1991

A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infection and Immunity 73(1): 325-333, 2004

Synthetic di, tri, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B specific epitopes that elicit protective antibodies in mice. Abstracts of the General Meeting of the American Society for Microbiology 100: 301, 2000

Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice. Infection and Immunity 69(2): 787-793, 2001

Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies. Clinical and Diagnostic Laboratory Immunology 12(6): 722-726, 2005

Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates. Infection and Immunity 57(4): 1078-1083, 1989

Do quantitative IgG levels predict the specific immune response to pneumococcal polysaccharide antigens ?. Journal of Allergy & Clinical Immunology 103(1 PART 2): S243, 1999

The role of immune and natural specific antibodies in immunologic paralysis and immunity of mice to pneumococcal polysaccharide type 3. Journal of Immunology 104(3): 656-664, 1970

Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates. Medical Microbiology and Immunology 181(1): 35-42, 1992

The use of immune stimulating complexes to generate a Type III pneumococcal polysaccharide specific IgG response in BALB/c mice. FASEB Journal 10(6): A1081, 1996

Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clinical and Vaccine Immunology 16(5): 636-645, 2009

Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A. Journal of Experimental Medicine 180(6): 2277-2286, 1994